Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Medical Waste Sharps Pharmaceuticals topic

No spam. Unsubscribe anytime.

Committee hears brief support for consolidating sharps and nonhazardous pharmaceuticals

3205353 · May 6, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

At a May 6 hearing the committee heard testimony supporting Senate Bill 139, which would allow consolidation of sharps and nonhazardous, nonradioactive pharmaceuticals in a single container that meets specified safety standards; proponents said the change improves efficiency in clinical settings and is voluntary.

Senate Bill 139 would allow sharps and certain nonhazardous, nonradioactive pharmaceuticals to be consolidated into a single container that meets specified safety standards, and proponents told the House Climate, Energy and Environment Committee on May 6 that the measure would improve operational efficiency in hospitals and clinics.

Tom Barrows, representing Stericycle, a medical and infectious waste disposal company, described the proposal as a modest expansion of current Oregon rules that would permit commingling of nonhazardous pharmaceuticals with sharps in settings such as emergency rooms and operating rooms. “This creates efficiencies in the hospital and clinic settings,” Barrows said, and he told the committee the change would be optional for facilities that choose to adopt it.

Erin, the staff presenter, summarized a dash‑a3 amendment posted online that clarifies the consolidated container would be used for treatment (not disposal) and requires an incinerator authorized by state or federal permit to accept the consolidated material for treatment. The bill previously passed the Senate committee without recorded opposition and Barrows said he was not aware of opposition to the current amendment.

The committee received no other public testimony on SB 139 at the hearing and closed the item. There was no committee vote at the May 6 session.

SB 139’s supporters said the bill is limited in scope, voluntary, and intended to reduce handling trips and safety risks in clinical workflows. The committee did not take action on the measure at the hearing.